Skip to content

SaberX Radianz R51005004LRecalls & reported problems

Cordis US Corp. · SABERX RADIANZ 5MM4CM 190 · Class 2

All models of SaberX Radianz (24)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
5
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 20705032081679), received between Jun 23, 2023 and Feb 18, 2026 — classified as 2 injuries, 3 malfunctions.

The most frequently reported specific device problem is “Burst Container or Vessel” (3 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 1 reportsDec 2023: 0 reportsJan 2024: 1 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 1 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Burst Container or Vessel3
  • Detachment of Device or Device Component1
  • Difficult to Remove1

Patient problems

  • No Clinical Signs, Symptoms or Conditions5

Recent adverse event reports

The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.

  • MalfunctionFeb 18, 2026Burst Container or Vessel

    AS REPORTED, THE BALLOON OF A 5MM X 4CM SABERX RADIANZ PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETER RUPTURED BEFORE REACHING NOMINAL PRESSURE. A 4MM X 4CM SABERX RADIANZ PTA BALLOON CATHETER WAS USED AS A REPLACEMENT TO PERFORM DILATION. AN UNKNOWN DRUG-COATED BALLOON (DCB) WAS THEN USED AND THE PROCEDURE WAS COMPLETED. THERE WERE NO REPORTED INJURIES TO THE PATIENT. THIS WAS DURING A SUPERFICIAL FEMORAL ARTERY (SFA) PROCEDURE IN WHICH A RADIAL APPROACH WAS USED. AN UNKNOWN GUIDEWIRE WAS INSERTED PRIOR TO USE OF THE 5MM X 4CM SABERX RADIANZ PTYA BALLOON CATHETER. ADDITIONAL INFORMATION WAS REQUESTED BUT AS UNAVAILABLE. THE DEVICE WILL NOT BE RETURNED FOR EVALUATION.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24378266 ↗
  • MalfunctionJan 22, 2024Burst Container or Vessel; Burst Container or Vessel

    AS REPORTED, THE BALLOON OF A 5MM X 4CM SABERX RADIANZ PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETER RUPTURED DURING ITS INITIAL DILATION TO NOMINAL PRESSURE. THERE WERE NO REPORTED INJURIES TO THE PATIENT. THIS WAS DURING A PROCEDURE TO TREAT A 90% STENOSED SUPERFICIAL FEMORAL ARTERY (SFA) LESION WHICH HAD SEVERE CALCIFICATION AND MILD TORTUOSITY. THE DEVICE WAS STORED, HANDLED, AND PREPPED PER THE INSTRUCTIONS FOR USE (IFU) AND MAINTAINED NEGATIVE PRESSURE DURING PREPARATION. THERE WERE NO DIFFICULTIES REMOVING ANY OF THE STERILE PACKAGING COMPONENTS. THE DEVICE WAS ABLE TO BE REMOVED EASILY FROM THE PATIENT AND REMAINED IN ONE PIECE DURING ITS REMOVAL. THE DEVICE WILL NOT BE RETURNED FOR EVALUATION.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18553031 ↗
  • MalfunctionNov 14, 2023Burst Container or Vessel; Burst Container or Vessel

    AS REPORTED, THE BALLOON OF A 5MM X 4CM 190CM SABERX RADIANZ PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETER RUPTURED DURING ITS INITIAL INFLATION TO 8 ATMOSPHERES (ATM). AS A RESULT, A DIFFERENT SIZED SABER PTA BALLOON CATHETER WAS USED AS A REPLACEMENT. THERE WERE NO REPORTED INJURIES TO THE PATIENT. THIS WAS DURING A PROCEDURE TO TREAT A LESION IN THE SUPERIOR FEMORAL ARTERY (SFA) WHICH HAD MILD CALCIFICATION AND MILD TORTUOSITY. THE DEVICE WAS STORED AND PREPPED PER THE INSTRUCTIONS FOR USE (IFU) AND THERE WAS NO DIFFICULTY REMOVING ANY OF THE STERILE PACKAGING COMPONENTS. THE BALLOON WAS ABLE TO MAINTAIN NEGATIVE PRESSURE DURING PREPARATION. THE DEVICE IS ABLE TO BE REMOVED EASILY FROM THE PATIENT AND REMAINED IN ONE PIECE DURING ITS REMOVAL. THE DEVICE WILL NOT BE RETURNED FOR EVALUATION.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18132580 ↗
  • InjuryOct 16, 2023Detachment of Device or Device Component; Detachment of Device or Device Component

    AS REPORTED, DURING A RADIAL PERIPHERAL CASE, A 6F 110CM BRITE TIP RADIANZ SHEATH PROLAPSED INTO THE RIGHT ATRIUM AND COILED. THE PATIENT WAS BRIEFLY THROWN INTO AN ARRYTHMIA, BUT CORRECTED ONCE SYSTEM WAS PULLED OUT OF RIGHT ATRIUM. ONCE PROLAPSE WAS CORRECTED, IT WAS DISCOVERED THAT THE SABERX RADIANZ 5MM X 40MM BALLOON CATHETER WAS DIFFICULT TO PULL OFF THE .018 NON-CORDIS 300CM WIRE, THE BALLOON BROKE OFF AND FRACTURED UPON PULLING OUT. THE DISTAL TIP WITH RADIOPAQUE MARKERS WAS STILL ON THE GUIDEWIRE, WHICH WAS SNARED FROM A LEFT FEMORAL ACCESS POINT USING A NON-CORDIS SNARE. THE PROCEDURE WAS COMPLETED FROM A FEMORAL ACCESS POINT, WITHOUT PATIENT INJURY OR OTHER INCIDENTS WITH A CORDIS PRODUCT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 17939814 ↗
  • InjuryJun 23, 2023Difficult to Remove; Difficult to Remove

    AS REPORTED A 5MM X 4 CM 190 SABERX RADIANZ PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) DILATION CATHETER ¿WRAPPED AROUND THE WIRE AND CAUSED IT TO PROLAPSE AT THE SHEATHS TIP¿, WHICH CAUSED THE PTA NOT TO COME OUT. THERE WAS LACK OF A LONG SHEATH. THE PHYSICIAN NEEDED TO TAKE IT OUT IN THE OPERATING ROOM. THE PATIENT WAS NOT HARMED AND WAS DISCHARGED THE NEXT DAY. THE DEVICE WAS BEING USED TO TREAT A BYPASS GRAFT. THERE WAS NO LESION CALCIFICATION OR VESSEL TORTUOSITY WITH NINETY PERCENT (90%) STENOSIS. THE DEVICE WAS STORED, HANDLED, AND PREPPED ACCORDING TO THE INSTRUCTIONS FOR USE (IFU). THERE WAS NO DIFFICULTY REMOVING THE PRODUCT FROM THE HOOP OR DIFFICULTY REMOVING THE PROTECTIVE BALLOON COVER NOR DIFFICULTY REMOVING THE STYLET OR ANY OF THE STERILE PACKAGING COMPONENTS. THERE WERE NO KINKS OR OTHER DAMAGES NOTED PRIOR TO INSERTING THE PRODUCT INTO THE PATIENT. THE DEVICE PREPPED NORMALLY, MAINTAINING NEGATIVE PRESSURE. THERE WAS NO RESISTANCE/FRICTION WHILE INSERTING THE BALLOON THROUGH THE ROTATING HEMOSTATIC VALVE OR WHILE INSERTING THE BALLOON THROUGH THE GUIDE CATHETER. THERE WAS NO DIFFICULTY ADVANCING THE BALLOON CATHETER THROUGH THE VESSEL OR CROSSING THE LESION. THE

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 17194799 ↗

Other Catheter, angioplasty, peripheral, transluminal devices

All Catheter, angioplasty, peripheral, transluminal devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page